Bridging the gap between risk and response.
Patients change between appointments — and by the time it shows, it's often an ER visit. As Louisiana's exclusive licensee of SYNC-PREVENT™, BridgeCare LA gives your team the clinical picture to act early: biomarker data, FDA-cleared devices, and longitudinal records across eight specialized programs, built to surface the signal before it becomes a hospitalization.
The only licensed operator of SYNC-PREVENT™ in Louisiana — deploying continuous clinical monitoring where it matters most.
BridgeCare Louisiana, LLC holds the exclusive license to deploy and operate SYNC-PREVENT™ across the state. Developed by Synchronize Health, LLC, SYNC-PREVENT™ is a clinical status monitoring platform integrating biomarker data, FDA-cleared device readings, and longitudinal patient records into a continuously updated picture of each patient's physiologic status.
Every program follows one principle: identify risk before symptoms appear, monitor continuously, and surface actionable intelligence to the ordering physician. The physician retains full clinical authority over every treatment decision. BridgeCare LA surfaces the data — it never makes the call.
Exclusive Louisiana Licensee
- Sole licensed operator of SYNC-PREVENT™ throughout Louisiana
- Biomarker-driven clinical interpretation with closed-loop care coordination
- FDA-cleared devices with real-time alerting and continuous data streams
- CMS-reimbursable under RPM, CCM, and standard billing codes
- Full EMR integration with the ordering physician
- Physician retains all clinical authority — always
Every signal that matters, across eight clinical pathways.
Heart Failure Prevention Protocol
Continuous Glucose Monitoring
Specialized Care CCM
Zero DFU Program
Inhaler Technique Monitoring
Grip Strength RA Monitoring
Ostomy Aftercare (S.O.A.P.)
Post-TAVR Monitoring
From risk identification to physician signal — the same clinical logic across every program.
Powered by SYNC-PREVENT™
SYNC-PREVENT™ is the clinical status monitoring platform at the core of every BridgeCare LA program. It unifies biomarker data, FDA-cleared device readings, and longitudinal patient records into one continuously updated physiologic picture per patient — so specialists know what changed, what matters, and what to ask before they pick up the phone.
BridgeCare LA is the only entity authorized to deploy SYNC-PREVENT™ in the state. The platform's clinical interpretation and care coordination infrastructure run underneath every one of the eight programs listed above.
The whole difference comes down to one thing: whether the person dialing already knows what this patient's own data has been signaling all along.
Built by Someone Who Saw the Gap Firsthand
Matthew E. Mazur, Jr.
President
Matthew E. Mazur, Jr. spent 25 years as an attorney in Florida, representing physicians across malpractice defense, general counsel, board proceedings, and regulatory matters. That work gave him an uncommon vantage point — not inside the exam room, but close enough to see what kept going wrong between visits.
The pattern was consistent: a patient leaves an appointment clinically stable, deteriorates over the following weeks with no one monitoring, and arrives at the emergency department in crisis. The data needed to intervene earlier — a trending weight change, a shifting lab value, a lapsed medication — often existed somewhere in the system. It simply never reached the physician in time to act.
Rather than design a solution in isolation, Matthew sought out leading clinical researchers who had spent their careers quantifying exactly this kind of preventable deterioration. He assembled a clinical advisory panel — including world-recognized experts in diabetes outcomes, health economics, and biomarker-driven risk modeling — and worked alongside them to architect SYNC-PREVENT™: a platform grounded in published evidence, built around FDA-cleared devices, and structured so that the physician retains full clinical authority at every step.
He founded Synchronize Health, LLC to develop and license the platform, and launched BridgeCare Louisiana, LLC as its exclusive operator in the state — bridging the gap between the risk the data reveals and the clinical response the patient needs.
Background
As president, Matthew oversees the development and deployment of SYNC-PREVENT™ across Louisiana — translating clinical research into operational monitoring programs that give physicians the structured picture they need to intervene weeks before a crisis, not after one.
BBA, University of Miami (1994). JD, University of Miami School of Law (1998), cum laude. Member of the Florida Bar. Admitted to the U.S. District Courts for the Southern and Northern Districts of Florida.
Clinical Advisory Panel
Guided by World-Class Expertise
Our advisory panel brings decades of leadership in diabetes research, health economics, and clinical innovation to shape how BridgeCare LA delivers monitoring that matters.
Vivian A. Fonseca, MD, FRCP
Professor of Medicine & Chief, Section of Endocrinology · Tulane University Medical Center
Past President for Science and Medicine of the American Diabetes Association. Professor of Medicine, Assistant Dean for Clinical Research, and holder of the Tullis-Tulane Alumni Chair in Diabetes at Tulane University.
Co-PI of REACHNET and site PI for the All of Us Program. Editor-in-Chief of Diabetes Care (2007–2011), with over 500 publications and an H-index of 109.
- ADA Banting Medal for Leadership & Service
- Fellow, Royal College of Physicians (London)
- Top 10 worldwide expert in Diabetes (Expertscape)
- Co-developer, BRAVO diabetes risk engine
Lizheng Shi, PhD, MsPharm, MA
Neal A. & Mary Vanselow Endowed Chair, Health Policy & Management · Tulane University
Founding Director of Tulane's Health Systems Analytics Research Center (HSARC). Clinical Faculty in Endocrinology and Psychiatry at Tulane's Department of Medicine.
PI and Co-PI for over 40 research grants from AHRQ, CDC, NIH, and PCORI. Over 300 peer-reviewed publications. Associate Editor of Value In Health and Co-Editor-in-Chief of Pharmacoeconomics and Policy.
- 2025 Hartzema Distinguished Speaker Award
- Pioneer in AI/ML for health policy evaluation
- Co-developer, BRAVO diabetes microsimulation model
- Expert in pharmacoeconomics & health technology assessment
Ready to close the gap between risk and response?
Talk to us about deploying clinical monitoring programs for your practice or health system across Louisiana.
Contact BridgeCare LA